A
Alto Neuroscience, Inc.
ANRO · NYSE · Healthcare · 1.1B
Price · close
$34.28
+0.09% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
6.5×
Enterprise value / EBITDAEV/EBITDA
-13.6×
Free cash flow yieldFCF yield
-5.2%
Return on equityROE
-41.8%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
2.9×
Interest coverage
-26.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.